JP2017524143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524143A5 JP2017524143A5 JP2017510438A JP2017510438A JP2017524143A5 JP 2017524143 A5 JP2017524143 A5 JP 2017524143A5 JP 2017510438 A JP2017510438 A JP 2017510438A JP 2017510438 A JP2017510438 A JP 2017510438A JP 2017524143 A5 JP2017524143 A5 JP 2017524143A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- schizophrenia
- loss
- disorder
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020035496A JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461986480P | 2014-04-30 | 2014-04-30 | |
| US61/986,480 | 2014-04-30 | ||
| PCT/US2015/028385 WO2015168346A1 (en) | 2014-04-30 | 2015-04-30 | Use of known compounds as d-amino acid oxidase inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020035496A Division JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017524143A JP2017524143A (ja) | 2017-08-24 |
| JP2017524143A5 true JP2017524143A5 (https=) | 2018-06-14 |
Family
ID=54359315
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017510438A Pending JP2017524143A (ja) | 2014-04-30 | 2015-04-30 | Ｄ−アミノ酸オキシダーゼ阻害剤としての既知の化合物の使用 |
| JP2020035496A Active JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020035496A Active JP6941326B2 (ja) | 2014-04-30 | 2020-03-03 | 疾患をｄ−アミノ酸オキシダーゼ（ｄａａｏ）阻害により治療するための医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9868975B2 (https=) |
| EP (2) | EP3498275B1 (https=) |
| JP (2) | JP2017524143A (https=) |
| KR (2) | KR102537686B1 (https=) |
| CN (2) | CN112773798B (https=) |
| AU (1) | AU2015253099B2 (https=) |
| CA (1) | CA2946153C (https=) |
| DK (1) | DK3137658T3 (https=) |
| ES (2) | ES2951736T3 (https=) |
| IL (1) | IL248567B (https=) |
| MX (2) | MX2016011551A (https=) |
| PT (1) | PT3137658T (https=) |
| SG (2) | SG11201607166XA (https=) |
| TW (1) | TWI675660B (https=) |
| WO (1) | WO2015168346A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3137658T (pt) * | 2014-04-30 | 2022-05-05 | Univ Nat Taiwan | Uso de compostos conhecidos como inibidores do d-aminoácido oxidase |
| EP3512840B1 (en) * | 2016-09-14 | 2024-03-06 | Yufeng Jane Tseng | Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors |
| CN108143734A (zh) * | 2018-02-09 | 2018-06-12 | 南京中医药大学 | 阿莫地喹及其药学上可接受的盐在制备用于治疗阿尔茨海默病的药物中的应用 |
| US20220016099A1 (en) * | 2018-12-06 | 2022-01-20 | Trinuero | Benzimidazole or benzoxazole derivatives for preventing and treating central nervous system disease, diabetes, and complications thereof |
| EP3915120A1 (en) * | 2019-01-23 | 2021-12-01 | The Regents of the University of Michigan | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
| CN110297839B (zh) * | 2019-06-25 | 2022-04-12 | 中国人民解放军军事科学院军事医学研究院 | 药物适应症的查询方法、装置、计算机设备和存储介质 |
| CA3166147A1 (en) * | 2021-06-23 | 2022-12-23 | Yoda Pharmaceuticals Inc. | Benzimidazole derivatives for treatment and/or prevention of diseases and disorders mediated by nlrp3 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619652A (en) | 1982-12-23 | 1986-10-28 | Alza Corporation | Dosage form for use in a body mounted pump |
| JPH0347123A (ja) | 1989-05-05 | 1991-02-28 | G D Searle & Co | インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物 |
| GB9208492D0 (en) | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| GB9304500D0 (en) | 1993-03-05 | 1993-04-21 | Glaxo Spa | Heterocyclic compounds |
| GB9321221D0 (en) | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
| JP3928000B2 (ja) * | 1995-11-13 | 2007-06-13 | 昭子 板井 | 生理活性化合物の設計方法 |
| CN1486180A (zh) * | 2000-12-07 | 2004-03-31 | 纽热莫勒丘乐有限公司 | 用nmda受体拮抗物治疗神经精神病紊乱的方法 |
| US20030162825A1 (en) | 2001-11-09 | 2003-08-28 | Sepracor Inc. | D-amino acid oxidase inhibitors for learning and memory |
| AU2003241464A1 (en) * | 2002-05-17 | 2003-12-02 | Eisai Co., Ltd. | Compositions and methods using proton pump inhibitors |
| CA2559105A1 (en) | 2004-03-16 | 2005-09-29 | Janssen Pharmaceutica N.V. | Benzisoxazoles |
| DE602005013372D1 (de) * | 2005-07-29 | 2009-04-30 | Rottapharm Spa | Kombination aus Itriglumid und PPI zur Behandlung von gastrointestinalen- und assozierten Krankheiten |
| US20090306169A1 (en) * | 2005-10-06 | 2009-12-10 | Brandish Philip E | Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors |
| US7960544B2 (en) * | 2005-12-16 | 2011-06-14 | Ironwood Pharmaceuticals, Inc. | Useful indole compounds |
| US9333260B2 (en) * | 2006-05-10 | 2016-05-10 | Laclede, Inc. | Compositions and methods for enzymatic treatment of lung disorders |
| EP2057162A2 (en) | 2006-06-30 | 2009-05-13 | Sepracor Inc. | Fused heterocyclic inhibitors of d-amino acid oxidase |
| US20090099248A1 (en) * | 2007-01-18 | 2009-04-16 | Sepracor Inc. | Inhibitors of d-amino acid oxidase |
| MX2010013247A (es) | 2008-06-02 | 2011-02-23 | Ironwood Pharmaceuticals Inc | Derivados de acido carboxilico selenazol y selenofeno. |
| JP4462382B1 (ja) * | 2009-04-23 | 2010-05-12 | 学校法人北里研究所 | Ｄ−アスパラギン酸オキシダーゼおよびｄ−アミノ酸オキシダーゼに対する新規阻害剤 |
| US20120035156A1 (en) * | 2010-08-09 | 2012-02-09 | Daniela Alberati | Combination of glyt1 compound with antipsychotics |
| JO3115B1 (ar) * | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| WO2013061161A2 (en) * | 2011-10-28 | 2013-05-02 | Green Bcn Consulting Services Sl | New combination therapies for treating neurological disorders |
| KR101348984B1 (ko) * | 2012-01-31 | 2014-01-10 | 전남대학교산학협력단 | 박테리아 시토크롬 ｐ450을 이용한 오메프라졸로부터 대사산물의 신규한 생산방법 및 이를 위한 조성물 |
| PT3137658T (pt) * | 2014-04-30 | 2022-05-05 | Univ Nat Taiwan | Uso de compostos conhecidos como inibidores do d-aminoácido oxidase |
-
2015
- 2015-04-30 PT PT157866112T patent/PT3137658T/pt unknown
- 2015-04-30 KR KR1020227029414A patent/KR102537686B1/ko active Active
- 2015-04-30 SG SG11201607166XA patent/SG11201607166XA/en unknown
- 2015-04-30 CN CN202011486413.7A patent/CN112773798B/zh active Active
- 2015-04-30 US US15/125,716 patent/US9868975B2/en not_active Ceased
- 2015-04-30 IL IL248567A patent/IL248567B/en unknown
- 2015-04-30 WO PCT/US2015/028385 patent/WO2015168346A1/en not_active Ceased
- 2015-04-30 US US16/401,892 patent/USRE49340E1/en active Active
- 2015-04-30 CN CN201580021632.9A patent/CN106687626B/zh active Active
- 2015-04-30 DK DK15786611.2T patent/DK3137658T3/da active
- 2015-04-30 JP JP2017510438A patent/JP2017524143A/ja active Pending
- 2015-04-30 KR KR1020167032409A patent/KR20160147868A/ko not_active Ceased
- 2015-04-30 EP EP19150604.7A patent/EP3498275B1/en active Active
- 2015-04-30 CA CA2946153A patent/CA2946153C/en active Active
- 2015-04-30 ES ES19150604T patent/ES2951736T3/es active Active
- 2015-04-30 EP EP15786611.2A patent/EP3137658B1/en active Active
- 2015-04-30 SG SG10202102125SA patent/SG10202102125SA/en unknown
- 2015-04-30 TW TW104114104A patent/TWI675660B/zh active
- 2015-04-30 AU AU2015253099A patent/AU2015253099B2/en active Active
- 2015-04-30 ES ES15786611T patent/ES2911879T3/es active Active
- 2015-04-30 MX MX2016011551A patent/MX2016011551A/es unknown
-
2016
- 2016-09-06 MX MX2021000133A patent/MX2021000133A/es unknown
-
2020
- 2020-03-03 JP JP2020035496A patent/JP6941326B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017524143A5 (https=) | ||
| O’Brien et al. | Vascular risk factors and Alzheimer’s disease | |
| EP4548918A3 (en) | Tricyclic compounds as inhibitors of kras | |
| JP2014505688A5 (https=) | ||
| FI3618875T3 (fi) | Raf-inhibiittoria ja trametinibia käsittävä yhdistelmähoito | |
| EP4218754A3 (en) | Methods of treatment for cystic fibrosis | |
| WO2016106331A8 (en) | Mutant idh1 inhibitors useful for treating cancer | |
| JP2016538257A5 (https=) | ||
| JP2019511460A5 (https=) | ||
| CN108463219B (zh) | 用于治疗化学治疗引起的周围神经病变的用途的il-8抑制剂 | |
| JP2016512198A5 (https=) | ||
| EA202190586A1 (ru) | N-замещенные диоксоциклобутениламино-3-гидроксипиколинамиды, приемлемые в качестве ингибиторов ccr6 | |
| EA020987B1 (ru) | Ассоциация между 4-{3-[цис-гексагидроциклопента[c]пиррол-2(1h)-ил]пропокси}бензамидом и ингибитором ацетилхолинэстеразы и фармацевтические композиции, которые ее содержат | |
| EA202090194A1 (ru) | Композиции статинов и способы их применения при лечении синуклеинопатий | |
| IL273922B1 (en) | D-amino acid oxidase inhibitors and therapeutic uses thereof | |
| Sun et al. | AMPAkines and morphine provide complementary analgesia | |
| JP2016537432A5 (https=) | ||
| US12527781B2 (en) | Treatment of neurodegenerative conditions by disruption of Rhes | |
| WO2018158150A1 (en) | Treatment of dementia with cannabinoid agonists | |
| JP2010520299A (ja) | ３−アリール−３−ヒドロキシ−２−アミノ−プロピオン酸アミド、３−ヘテロアリール−３−ヒドロキシ−２−アミノ−プロピオン酸アミドおよび関連化合物を使用する認知障害の処置方法 | |
| WO1993019757A1 (fr) | Emploi des derives de la phenothiazine dans le traitement de l'ischemie et/ou de l'hypoxie | |
| JP6483627B2 (ja) | 脳内アミロイドβ蓄積症の予防または治療剤 | |
| Retinasamy et al. | Aducanumab for Alzheimer's disease: An update | |
| JP4964593B2 (ja) | 神経学的病状の治療用のテトラヒドロインドロン誘導体 | |
| MX2024007043A (es) | Purinas y métodos de uso. |